Rituximab for IgG4-related disease: a prospective, open-label trial von Carruthers, Mollie N, Topazian, Mark D, Khosroshahi, Arezou, Witzig, Thomas E, Wallace, Zachary S, Hart, Philip A, Deshpande, Vikram, Smyrk, Thomas C, Chari, Suresh, Stone, John H

Volltext

Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study von GOY, Andre, SINHA, Rajni, WILLIAMS, Michael E, BESISIK, Sevgi Kalayoglu, DRACH, Johannes, RAMCHANDREN, Radhakrishnan, LEI ZHANG, CICERO, Sherri, FU, Tommy, WITZIG, Thomas E

Volltext

SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas von Chen, Linfeng, Monti, Stefano, Juszczynski, Przemyslaw, Ouyang, Jing, Chapuy, Bjoern, Neuberg, Donna, Doench, John G., Bogusz, Agata M., Habermann, Thomas M., Dogan, Ahmet, Witzig, Thomas E., Kutok, Jeffery L., Rodig, Scott J., Golub, Todd, Shipp, Margaret A.

Volltext

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412 von Nowakowski, Grzegorz S, Hong, Fangxin, Scott, David W, Macon, William R, King, Rebecca L, Habermann, Thomas M, Wagner-Johnston, Nina, Casulo, Carla, Wade, James L, Nagargoje, Gauri G, Reynolds, C M, Cohen, Jonathon B, Khan, Nadia, Amengual, Jennifer E, Richards, Kristy L, Little, R F, Leonard, John P, Friedberg, Jonathan W, Kostakoglu, Lale, Kahl, Brad S, Witzig, Thomas E

Volltext

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials von Maurer, Matthew J, Ghesquières, Hervé, Link, Brian K, Jais, Jean-Philippe, Habermann, Thomas M, Thompson, Carrie A, Haioun, Corinne, Allmer, Cristine, Johnston, Patrick B, Delarue, Richard, Micallef, Ivana N, Peyrade, Frederic, Inwards, David J, Ketterer, Nicolas, Farooq, Umar, Fitoussi, Olivier, Macon, William R, Molina, Thierry J, Syrbu, Sergei, Feldman, Andrew L, Slager, Susan L, Weiner, George J, Ansell, Stephen M, Cerhan, James R, Salles, Gilles A, Witzig, Thomas E, Tilly, Hervé, Nowakowski, Grzegorz S

Volltext

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence... von LINK, Brian K, MAURER, Matthew J, COLGAN, Joseph P, WITZIG, Thomas E, HABERMANN, Thomas M, CERHAN, James R, NOWAKOWSKI, Grzegorz S, ANSELL, Stephen M, MACON, William R, SYRBU, Sergei I, SLAGER, Susan L, THOMPSON, Carrie A, INWARDS, David J, JOHNSTON, Patrick B

Volltext

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma von Maurer, Matthew J., Bachy, Emmanuel, Ghesquières, Hervé, Ansell, Stephen M., Nowakowski, Grzegorz S., Thompson, Carrie A., Inwards, David J., Allmer, Cristine, Chassagne‐Clément, Catherine, Nicolas‐Virelizier, Emmanuelle, Sebban, Catherine, Lebras, Laure, Sarkozy, Clementine, Macon, William R., Feldman, Andrew L., Syrbu, Sergei I., Traverse‐Glehan, Alexandra, Coiffier, Bertrand, Slager, Susan L., Weiner, George J., Witzig, Thomas E., Habermann, Thomas M., Salles, Gilles, Cerhan, James R., Link, Brian K.

Volltext

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas von Braggio, Esteban, Van Wier, Scott, Ojha, Juhi, McPhail, Ellen, Asmann, Yan W, Egan, Jan, da Silva, Jackline Ayres, Schiff, David, Lopes, M Beatriz, Decker, Paul A, Valdez, Riccardo, Tibes, Raoul, Eckloff, Bruce, Witzig, Thomas E, Stewart, A Keith, Fonseca, Rafael, O'Neill, Brian Patrick

Volltext

Targeting Apoptosis Pathways in Cancer Therapy von Ghobrial, Irene M, Witzig, Thomas E, Adjei, Alex A

Volltext

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma von Thompson, Carrie A, Ghesquieres, Herve, Maurer, Matthew J, Cerhan, James R, Biron, Pierre, Ansell, Stephen M, Chassagne-Clément, Catherine, Inwards, David J, Gargi, Thérèse, Johnston, Patrick B, Nicolas-Virelizier, Emmanuelle, Macon, William R, Peix, Marie, Micallef, Ivana N, Sebban, Catherine, Nowakowski, Grzegorz S, Porrata, Luis F, Weiner, George J, Witzig, Thomas E, Habermann, Thomas M, Link, Brian K

Volltext

CODOX-M/IVAC-R versus DA-EPOCH-R in double hit/triple hit lymphoma patients aged 60 years or under von Atallah-Yunes, Suheil Albert, Rees, Matthew J, Witzig, Thomas E, Habermann, Thomas M, Munoz, Javier, Iqbal, Madiha, McPhail, Ellen D, Nowakowski, Grzegorz S

Volltext

Higher response to lenalidomide in relapsed/refractory diffuse large B‐cell lymphoma in nongerminal center B‐cell–like than in germinal center B‐cell–like phenotype von Hernandez‐Ilizaliturri, Francisco J., Deeb, George, Zinzani, Pier L., Pileri, Stefano A., Malik, Farhana, Macon, William R., Goy, Andre, Witzig, Thomas E., Czuczman, Myron S.

Volltext

Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma von Lin, Yi, Gustafson, Michael P., Bulur, Peggy A., Gastineau, Dennis A., Witzig, Thomas E., Dietz, Allan B.

Volltext

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements von McPhail, Ellen D, Maurer, Matthew J, Macon, William R, Feldman, Andrew L, Kurtin, Paul J, Ketterling, Rhett P, Vaidya, Rakhee, Cerhan, James R, Ansell, Stephen M, Porrata, Luis F, Nowakowski, Grzegorz S, Witzig, Thomas E, Habermann, Thomas M

Volltext

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma von PORRATA, Luis F, RISTOW, Kay, THOMPSON, Carrie, MARKOVIC, Svetomir N, COLGAN, Joseph P, HABERMANN, Thomas M, WITZIG, Thomas E, INWARDS, David J, ANSELL, Stephen M, MICALLEF, Ivana N, JOHNSTON, Patrick B, NOWAKOWSKI, Grzegorz S

Volltext

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation von Gupta, Mamta, Han, Jing Jing, Stenson, Mary, Maurer, Matthew, Wellik, Linda, Hu, Guangzhen, Ziesmer, Steve, Dogan, Ahmet, Witzig, Thomas E.

Volltext

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma von Chen, Linfeng, Monti, Stefano, Juszczynski, Przemyslaw, Daley, John, Chen, Wen, Witzig, Thomas E., Habermann, Thomas M., Kutok, Jeffery L., Shipp, Margaret A.

Volltext

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma von Wang, Yucai, Link, Brian K., Witzig, Thomas E., Maurer, Matthew J., Allmer, Cristine, King, Rebecca L., Feldman, Andrew L., Habermann, Thomas M., Ansell, Stephen M., Slager, Susan L., Cerhan, James R., Nowakowski, Grzegorz S.

Volltext

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study von Cerhan, James R, Link, Brian K, Habermann, Thomas M, Maurer, Matthew J, Feldman, Andrew L, Syrbu, Sergei I, Thompson, Carrie A, Farooq, Umar, Novak, Anne J, Slager, Susan L, Allmer, Cristine, Lunde, Julianne J, Macon, William R, Inwards, David J, Johnston, Patrick B, Micallef, Ivana N M, Nowakowski, Grzegorz S, Ansell, Stephen M, Kay, Neil E, Weiner, George J, Witzig, Thomas E

Volltext

Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease von Majumder, Shounak, Mohapatra, Sonmoon, Lennon, Ryan J., Piovezani Ramos, Guilherme, Postier, Neil, Gleeson, Ferga C., Levy, Michael J., Pearson, Randall K., Petersen, Bret T., Vege, Santhi Swaroop, Chari, Suresh T., Topazian, Mark D., Witzig, Thomas E.

Volltext